Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) — Cash Flow Quality Index
Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) has a Cash Flow Quality Index of 1.19x as of September 2025. Operating cash flow of CN¥670.83 Million exceeds net income of CN¥564.54 Million, indicating high earnings quality where cash backs reported profits. Explore Shanghai Allist Pharmaceuticals Co. Ltd. (688578) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shanghai Allist Pharmaceuticals Co. Ltd. A Cash Flow Quality Index (2021–2025)
Historical Cash Flow Quality Index for Shanghai Allist Pharmaceuticals Co. Ltd. A across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Shanghai Allist Pharmaceuticals Co. Ltd. (688578) cash conversion ratio.
Annual Cash Flow Quality Index for Shanghai Allist Pharmaceuticals Co. Ltd. A (2021–2025)
Year-by-year earnings quality comparison for Shanghai Allist Pharmaceuticals Co. Ltd. A.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.06x | CN¥2.32 Billion | CN¥2.18 Billion | ▼ -2.8% |
| 2024 | 1.10x | CN¥1.57 Billion | CN¥1.43 Billion | ▲ +4.6% |
| 2023 | 1.05x | CN¥674.65 Million | CN¥644.17 Million | ▲ +49.2% |
| 2022 | 0.70x | CN¥91.63 Million | CN¥130.52 Million | ▼ -56.2% |
| 2021 | 1.60x | CN¥29.29 Million | CN¥18.27 Million | — |